Biological raw materials/scientific research achievements transformation platform
Anhui Huibang Biological Engineering Co., Ltd. (hereinafter referred to as "Huibang biology") was founded in May 2013. It is a national high-tech enterprise dedicated to the integration of R & D, production and sales of chronic disease (diabetic nephropathy) detection reagents, maternal and child health care diagnostic reagents, cardiovascular disease detection reagents, tumor and other diagnostic reagents and monoclonal antibody raw materials for diagnosis. It covers an area of 40 mu with a total investment of 0.45 billion yuan. Has obtained more than 50 national patent certificate. In April 2019, listed in the Anhui Province Equity Custody Trading Center, listing code: 630215.
The transformation and industrialization of basic life science research to clinical applications requires the participation of enterprises in building a platform. Huibang Biology actively and deeply participates in basic life science research and the transformation of scientific research achievements, builds a platform for cooperation and industrialization of scientific research achievements transformation, cooperates with scientists in a variety of ways, continuously invests enterprise funds to support and promotes the landing of industrialization and marketization, so as to make the connection between basic research and the transformation of scientific research achievements more quickly and effectively, and promote the development of the transformation of scientific research achievements.